Q1 EPS Forecast for OnKure Therapeutics Reduced by Analyst
OnKure Therapeutics (NASDAQ:OKUR – Free Report) – Equities research analysts at HC Wainwright dropped their Q1 2025 earnings per share (EPS) estimates for shares of OnKure Therapeutics in a research note issued on Tuesday, March 18th. HC Wainwright analyst R. Burns now expects that the company will post earnings of ($1.41) per share for the […]
